Clinical Trials in Salt Lake City

Showing 3201-3220 of 16,694 trials

Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants

NCT03169881

Study Hypothesis: Preterm infants administered weekly Darbe during the neonatal period will have improved neurocognitive outcome at 22-26 months compared to placebo

NeurocognitiveNeuroprotectiveNeonatal+1 more

NICHD Neonatal Research Network650 participantsStarted Sep 2017

Birmingham, Alabama, United States • Palo Alto, California, United States • Atlanta, Georgia, United States +13 more locations

COMPLETEDPhase 3< 1 mile

A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome

NCT03936777

This is an international, multicenter, open-label, long-term safety study of ZX008 in subjects with Dravet syndrome, Lennox-Gastaut syndrome or epileptic encephalopathy

Dravet SyndromeLennox Gastaut SyndromeEpileptic Encephalopathy

Zogenix, Inc.412 participantsStarted Apr 2019

Tucson, Arizona, United States • Los Angeles, California, United States • San Diego, California, United States +68 more locations

Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants

A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome

Find Trials by Condition in Salt Lake City

SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM

Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors

M6-C Artificial Cervical Disc Two-Level IDE Pivotal Study

Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression

Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3)

A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects With Arterial Disease Below the Knee (STAND)

A Study of PF-06873600 in People With Cancer

Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL

Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2

A Study to Assess BOTOX Injections for the Change of Masseter Muscle Prominence in Adult Participants

A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

Delirium in Children Undergoing Stem Cell Transplantation

Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease

Safety Study of PP-007 in Subjects With Acute Ischemic Stroke

Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)

Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism